Send to a Friend Font Size: Increase Decrease

2395 and STSA Related Headlines

Nov 5, 2025 08:00AM Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache

2395 and STSA Related Press Releases

Nov 5, 2025 08:00AM Satsuma Pharmaceuticals and SNBL Announce Publication of Impression of Use and Satisfaction with STS101 (Dihydroergotamine Nasal Powder (Atzumi™)) in Headache

2395 and STSA Related SEC Filings